Back to Search Start Over

CSF/serum matrix metallopeptidase‐9 ratio discriminates neuro Behçet from multiple sclerosis.

Authors :
Aldinucci, Alessandra
Bonechi, Elena
Biagioli, Tiziana
Repice, Anna M.
D'Elios, Mario M.
Emmi, Lorenzo
Emmi, Giacomo
Silvestri, Elena
Barilaro, Alessandro
Ballerini, Clara
Source :
Annals of Clinical & Translational Neurology; Apr2018, Vol. 5 Issue 4, p493-498, 6p
Publication Year :
2018

Abstract

Abstract: In neuro Behçet disease with multiple sclerosis‐like features, diagnosis could be challenging. Here, we studied the cerebrospinal fluid and serum inflammatory profile of 11 neuro Behçet and 21 relapsing‐remitting multiple sclerosis patients. Between the soluble factors analyzed (MMP9, TNF<italic>α</italic>, IL6, CXCL13, CXCL10, CXCL8, IFN<italic>γ</italic>, IL10, IL17, IL23, and others) we found MMP9 increased in neuro Behçet serum compared to multiple sclerosis and decreased in cerebrospinal fluid. Furthermore, neuro Behçet analysis of circulating natural killer CD56<subscript>DIM</subscript> subset suggests their potential involvement in increased MMP9 production. We believe that these findings may have a translational utility in clinical practice. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
23289503
Volume :
5
Issue :
4
Database :
Complementary Index
Journal :
Annals of Clinical & Translational Neurology
Publication Type :
Academic Journal
Accession number :
129078307
Full Text :
https://doi.org/10.1002/acn3.538